Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1998;83:396-403

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pellacani, A.
Right arrow Articles by Perrella, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pellacani, A.
Right arrow Articles by Perrella, M. A.
(Circulation Research. 1998;83:396-403.)
© 1998 American Heart Association, Inc.


Original Contributions

Induction of Heme Oxygenase-1 During Endotoxemia Is Downregulated by Transforming Growth Factor-ß1

Andrea Pellacani1, Philippe Wiesel1, Arunabh Sharma, Lauren C. Foster, Gordon S. Huggins, Shaw-Fang Yet, , Mark A. Perrella

From the Cardiovascular Biology Laboratory, Harvard School of Public Health (A.P., P.W., L.C.F., G.S.H., S.-F.Y., M.A.P.), the Department of Medicine, Harvard Medical School (A.S., G.S.H., M.A.P.), the Cardiac Unit, Massachusetts General Hospital (G.S.H.), and the Pulmonary and Critical Care Division, Brigham and Women's Hospital (A.S., M.A.P.), Boston, Mass.

Correspondence to Mark A. Perrella, MD, Cardiovascular Biology Laboratory, Building 2, Harvard School of Public Health, 677 Huntington Ave, Boston, MA 02115. E-mail perrella{at}cvlab.harvard.edu

Abstract—Heme oxygenase (HO)-1 generates CO, a gas with vasodilatory properties, during heme metabolism. HO-1 is expressed highly in vascular tissue after endotoxin stimulation, and generation of CO through the HO-1 pathway contributes to the hemodynamic compromise of endotoxic shock. Shock related to endotoxemia is an immune-mediated process that involves the generation of proinflammatory cytokines such as interleukin (IL)-1ß. Because transforming growth factor (TGF)-ß1 is a modulator of immune-mediated inflammatory responses and it blocks the hypotension of endotoxic shock, we determined whether TGF-ß1 could be used to reduce expression of HO-1 in vascular tissue and smooth muscle cells. In a rat model of endotoxic shock, lipopolysaccharide-induced HO-1 mRNA and protein expression was reduced by TGF-ß1 in highly vascularized tissue, such as heart and lung, by Northern and Western analysis. Furthermore, TGF-ß1 downregulated HO-1 mRNA after its induction by IL-1ß in vascular smooth muscle cells in culture. TGF-ß1 also decreased HO-1 but not HO-2 protein expression in these cells. TGF-ß1 decreased HO enzyme activity induced in IL-1ß–treated vascular smooth muscle cells to a level not different from that in vehicle-treated cells. These studies suggest that this downregulation of HO-1 mRNA and protein expression and decrease in IL-1ß–induced HO enzyme activity may contribute to the beneficial effect of TGF-ß1 on endotoxic shock.


Key Words: vascular smooth muscle cell • endotoxic shock • gene expression • enzyme activity




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
Y. Wei, X.-m. Liu, K. J. Peyton, H. Wang, F. K. Johnson, R. A. Johnson, and W. Durante
Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival
Am J Physiol Cell Physiol, October 1, 2009; 297(4): C907 - C915.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
Q. Ye, Y. Dalavanga, N. Poulakis, S. U. Sixt, J. Guzman, and U. Costabel
Decreased expression of haem oxygenase-1 by alveolar macrophages in idiopathic pulmonary fibrosis
Eur. Respir. J., May 1, 2008; 31(5): 1030 - 1036.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Stocker and M. A. Perrella
Heme Oxygenase-1: A Novel Drug Target for Atherosclerotic Diseases?
Circulation, November 14, 2006; 114(20): 2178 - 2189.
[Full Text] [PDF]


Home page
J. Immunol.Home page
S. W. Chung, Y.-H. Chen, S.-F. Yet, M. D. Layne, and M. A. Perrella
Endotoxin-Induced Down-Regulation of Elk-3 Facilitates Heme Oxygenase-1 Induction in Macrophages
J. Immunol., February 15, 2006; 176(4): 2414 - 2420.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. W. Chung, Y.-H. Chen, and M. A. Perrella
Role of Ets-2 in the Regulation of Heme Oxygenase-1 by Endotoxin
J. Biol. Chem., February 11, 2005; 280(6): 4578 - 4584.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. E. Szabo, E. Gallyas, I. Bak, A. Rakotovao, F. Boucher, J. de Leiris, N. Nagy, E. Varga, and A. Tosaki
Heme Oxygenase-1-Related Carbon Monoxide and Flavonoids in Ischemic/Reperfused Rat Retina
Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3727 - 3732.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. M. Sikorski, T. Hock, N. Hill-Kapturczak, and A. Agarwal
The story so far: molecular regulation of the heme oxygenase-1 gene in renal injury
Am J Physiol Renal Physiol, March 1, 2004; 286(3): F425 - F441.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
F. A. D. T. G. Wagener, H.-D. Volk, D. Willis, N. G. Abraham, M. P. Soares, G. J. Adema, and C. G. Figdor
Different Faces of the Heme-Heme Oxygenase System in Inflammation
Pharmacol. Rev., September 1, 2003; 55(3): 551 - 571.
[Abstract] [Full Text] [PDF]


Home page
Exp Biol MedHome page
Y.-H. Chen, S.-F. Yet, and M. A. Perrella
Role of Heme Oxygenase-1 in the Regulation of Blood Pressure and Cardiac Function
Exp Biol Med, May 1, 2003; 228(5): 447 - 453.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Wiesel, A. P. Patel, N. DiFonzo, P. B. Marria, C. U. Sim, A. Pellacani, K. Maemura, B. W. LeBlanc, K. Marino, C. M. Doerschuk, et al.
Endotoxin-Induced Mortality Is Related to Increased Oxidative Stress and End-Organ Dysfunction, Not Refractory Hypotension, in Heme Oxygenase-1-Deficient Mice
Circulation, December 12, 2000; 102(24): 3015 - 3022.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. R. DiChiara, J. M. Kiely, M. A. Gimbrone Jr., M.-E. Lee, M. A. Perrella, and J. N. Topper
Inhibition of E-Selectin Gene Expression by Transforming Growth Factor {beta} in Endothelial Cells Involves Coactivator Integration of Smad and Nuclear Factor {kappa}B-Mediated Signals
J. Exp. Med., September 5, 2000; 192(5): 695 - 704.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. M Shah
Inducible nitric oxide synthase and cardiovascular disease
Cardiovasc Res, January 1, 2000; 45(1): 148 - 155.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Wiesel, L. C. Foster, A. Pellacani, M. D. Layne, C.-M. Hsieh, G. S. Huggins, P. Strauss, S.-F. Yet, and M. A. Perrella
Thioredoxin Facilitates the Induction of Heme Oxygenase-1 in Response to Inflammatory Mediators
J. Biol. Chem., August 4, 2000; 275(32): 24840 - 24846.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Hill-Kapturczak, L. Truong, V. Thamilselvan, G. A. Visner, H. S. Nick, and A. Agarwal
Smad7-dependent Regulation of Heme Oxygenase-1 by Transforming Growth Factor-beta in Human Renal Epithelial Cells
J. Biol. Chem., December 22, 2000; 275(52): 40904 - 40909.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S.-F. Yet, R. Tian, M. D. Layne, Z. Y. Wang, K. Maemura, M. Solovyeva, B. Ith, L. G. Melo, L. Zhang, J. S. Ingwall, et al.
Cardiac-Specific Expression of Heme Oxygenase-1 Protects Against Ischemia and Reperfusion Injury in Transgenic Mice
Circ. Res., July 20, 2001; 89(2): 168 - 173.
[Abstract] [Full Text] [PDF]